Shift Bioscience

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a biotechnology company intended to develop simulation-guided cell rejuvenation therapies to address the diseases of aging. Shift Bioscience is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $30.5 million. It has raised $17.5 million.

Last price · $/share
—
Implied valuation
$30.5M
Total raised
$17.5M
Last round
—
What is Shift Bioscience worth?
$30.5Mlast known valuation
Free account
More of Shift Bioscience with a free account
  • ·The complete investor list: 13 names
  • ·Watch Shift Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Shift Bioscience funding history

No rounds on record

No funding rounds for Shift Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Shift Bioscience valuation

Shift Bioscience's last known valuation is $30.5 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Shift Bioscience's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Shift Bioscience, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Shift Bioscience

What is Shift Bioscience worth?
Shift Bioscience's last known valuation is $30.5M.
How much has Shift Bioscience raised?
Shift Bioscience has raised $17.5M in total funding across its recorded rounds.